Journal for ImmunoTherapy of Cancer (Nov 2023)
1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment
Abstract
No abstracts available.